Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 316 citing GUTTERMAN: Leukocyte interferon-induced tumor regression in human metastatic breast cancer,.... (0.08 sec) 

Cytokine therapeutics: lessons from interferon alpha.

- pnas.org [PDF] 
JU Gutterman - Proceedings of the National Academy of …, 1994 - National Acad Sciences
ABSTRACT Cytokines are soluble proteins that allow for communication be- tween cells and the
external environment. Interferon (IFN) a, the first cytokine to be produced by recombinant DNA
technol- ogy, has emerged as an ...
Cited by 570 - Related articles - BL Direct - All 8 versions

Clinical toxicity of interferons in cancer patients: a review

- ascopubs.org [PDF] 
JR Quesada, M Talpaz, A Rios, R Kurzrock, … - Journal of Clinical …, 1986 - jco.ascopubs.org
A GREAT INTEREST in interferons (IFNs) in cancer treatment has gradually arisen since partially
purified human leukocyte IFN (IFNa) became available for clinical investiga- tion.' 2 In the past 10
years, numerous biologic activities ...
Cited by 415 - Related articles - All 6 versions

Clinical effects and toxicity of interleukin-2 in patients with cancer.


MT Lotze, YL Matory, AA Rayner, SE Ettinghausen, JT … - Cancer, 1986 - ncbi.nlm.nih.gov
Interleukin-2 (IL-2) is a 15,000 dalton glycoprotein produced naturally by human T-cells during an
immune response. IL-2 has been demonstrated to have substantial activity alone or in combination
with the adoptive transfer of ...
Cited by 229 - Related articles - All 2 versions

Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous …

- hematologylibrary.org [PDF] 
M Talpaz, KB McCredie, GM Mavligit, JU … - Blood, 1983 - bloodjournal.hematologylibrary.org
. Hematology; all rights reserved Copyright 2007 by The American Society of DC 20036. by the
American Society of Hematology, 1900 M St, NW, Suite 200, Washington Blood (print ISSN 0006-4971,
online ISSN 1528-0020), is ...
Cited by 225 - Related articles - All 4 versions

Kaposi's sarcoma***:: Epidemiology, pathogenesis, histology, clinical spectrum, …


JW Tappero, MA Conant, SF Wolfe, TG Berger - Journal of the American …, 1993 - Elsevier
The acquired immunodeficiency syndrome (AIDS) epidemic has had a profound impact on our
understanding of Kaposi's sarcoma (KS). Epidemiologic features suggest a sexually transmitted
cofactor in the pathogenesis of ...
Cited by 211 - Related articles - BL Direct - All 5 versions

Neuropsychiatric manifestations of human leukocyte interferon therapy in patients …


F Adams, JR Quesada, JU Gutterman - Jama, 1984 - Am Med Assoc
The conditions of ten patients with metastatic renal cell carcinoma were serially evaluated by
neuropsychiatric examination to determine the nature of the fatigue-asthenia symptoms resulting from
human leukocyte interferon alpha ...
Cited by 217 - Related articles - All 4 versions

[PDF] Biological response modifiers: the new immunotherapy


KA Foon… - Cancer Res, 1989 - AACR
Immunotherapy is divided into two overlapping categories, active and passive. The goal of active
immunotherapy is the stimulation of host ant ¡tumorimmunity, either cellular or hu moral. This
can be accomplished in a direct or ...
Cited by 166 - Related articles - All 3 versions

Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with …

- jcojournal.org [PDF] 
FX Real, HF Oettgen, SE Krown - Journal of Clinical Oncology, 1986 - jcojournal.org
The efficacy of recombinant leukocyte A interferon (rlFN-aA [Roferon-A, Hoffman-La Roche, Nutley,
NJ]) treatment of Kaposi's sarcoma in patients with ac- quired immunodeficiency syndrome was
evaluated in sequential trials ...
Cited by 157 - Related articles - All 5 versions

Weekly paclitaxel improves pathologic complete remission in operable breast …

- ascopubs.org [PDF] 
MC Green, AU Buzdar, T Smith, NK Ibrahim, V … - Journal of Clinical …, 2005 - jco.ascopubs.org
Daniel J. Hicklin and Lee M. Ellis From the Department of Experimental Therapeutics, ImClone Systems
Incorporated, New York, NY; and Departments of Surgical Oncology and Cancer Biology, The University
of Texas MD Anderson Cancer Center, ...
Cited by 143 - Related articles - All 10 versions

Safety and tolerance of recombinant interferon alfa-2a (Roferon®-A) in cancer …


GJ Jones, LM Itri - CA A Cancer Journal for Clinicians - interscience.wiley.com
Recombinant interferon alfa-2a (Roferon®-AHoffmann-La Roche Inc. NutleyNJ) has been evaluated in
clinical trials of more than 1300 patients with a broad spectrum of oncologic disease. Patients with
either solid tumors or hematologic ...
Cited by 120 - Related articles - All 2 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google